Quancheng Kan

1.5k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Quancheng Kan is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Quancheng Kan has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Quancheng Kan's work include Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). Quancheng Kan is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), RNA modifications and cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). Quancheng Kan collaborates with scholars based in China and United States. Quancheng Kan's co-authors include Zujiang Yu, Zhenfeng Duan, Huirong Shi, Francis J. Hornicek, Ranran Sun, Guangying Cui, Ang Li, Benchen Rao, Zhengwei Mao and Liangjie Hong and has published in prestigious journals such as Advanced Materials, Scientific Reports and Experimental Cell Research.

In The Last Decade

Quancheng Kan

30 papers receiving 1.2k citations

Hit Papers

A Metal–Polyphenol‐Coordi... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Metal–Polyphenol‐Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy
    2019 387 citations Ranran Sun, Zujiang Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quancheng Kan China 16 486 352 350 225 206 30 1.2k
Lihua Du China 16 514 1.1× 426 1.2× 237 0.7× 140 0.6× 217 1.1× 28 1.1k
Meng Jia China 19 482 1.0× 427 1.2× 262 0.7× 220 1.0× 130 0.6× 36 1.4k
Shanzhou Duan China 19 529 1.1× 302 0.9× 261 0.7× 207 0.9× 92 0.4× 40 1.2k
Fengming You China 24 589 1.2× 452 1.3× 258 0.7× 216 1.0× 120 0.6× 94 1.4k
Krishnendu Pal United States 20 607 1.2× 182 0.5× 280 0.8× 156 0.7× 119 0.6× 34 1.2k
Bin Kong China 21 596 1.2× 420 1.2× 150 0.4× 218 1.0× 250 1.2× 47 1.6k
Renata Jaskula‐Sztul United States 27 1.0k 2.2× 286 0.8× 508 1.5× 205 0.9× 128 0.6× 67 1.9k
Fangfang Chen China 15 520 1.1× 335 1.0× 133 0.4× 352 1.6× 204 1.0× 44 1.2k
Xiao Xu China 21 615 1.3× 475 1.3× 222 0.6× 306 1.4× 123 0.6× 56 1.3k

Countries citing papers authored by Quancheng Kan

Since Specialization
Citations

This map shows the geographic impact of Quancheng Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quancheng Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quancheng Kan more than expected).

Fields of papers citing papers by Quancheng Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quancheng Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quancheng Kan. The network helps show where Quancheng Kan may publish in the future.

Co-authorship network of co-authors of Quancheng Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Quancheng Kan. A scholar is included among the top collaborators of Quancheng Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quancheng Kan. Quancheng Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Bo, Yu Jia, Xianbin Li, et al.. (2025). YBX1 is required for maintaining PD-L1 expression in intrahepatic cholangiocarcinoma by regulating STAT1 stability in an m5C-dependent manner. Hepatobiliary & pancreatic diseases international. 24(6). 643–655. 1 indexed citations
2.
Wang, Han, Yueqin Wang, Lan Huang, et al.. (2025). Targeting YBX1‐m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma. Clinical and Translational Medicine. 15(3). e70270–e70270. 9 indexed citations
3.
Li, Feng, et al.. (2024). Clinical and genetic characteristics of patients with TRG 0 and TRG III in esophageal squamous cell carcinoma after neoadjuvant therapy. Scientific Reports. 14(1). 17708–17708. 1 indexed citations
4.
Guo, Xiangqian, et al.. (2021). Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma. Frontiers in Genetics. 12. 568779–568779. 1 indexed citations
5.
Gao, Yaping, et al.. (2021). EGR1-CCL2 Feedback Loop Maintains Epithelial-Mesenchymal Transition of Cisplatin-Resistant Gastric Cancer Cells and Promotes Tumor Angiogenesis. Digestive Diseases and Sciences. 67(8). 3702–3713. 13 indexed citations
6.
Xue, Wenhua, Dan Yan, & Quancheng Kan. (2019). Interleukin-35 as an Emerging Player in Tumor Microenvironment. Journal of Cancer. 10(9). 2074–2082. 29 indexed citations
7.
Shen, Shen, Dylan C. Dean, Zujiang Yu, et al.. (2019). Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067. Journal of Cancer. 11(1). 132–141. 18 indexed citations
8.
Li, Duolu, Xinru Wang, Meng Yang, Quancheng Kan, & Zhenfeng Duan. (2019). miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint. Experimental Cell Research. 380(1). 20–28. 43 indexed citations
9.
Zhou, Yubing, Jacson Shen, Zujiang Yu, et al.. (2018). Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(5). 1573–1582. 54 indexed citations
10.
11.
Huang, Jianmin, Quancheng Kan, Lan Lan, et al.. (2017). Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer. International Immunopharmacology. 46. 170–177. 15 indexed citations
12.
Liu, Fei, et al.. (2017). Management of and risk factors for regional recurrence in upper lip squamous cell carcinoma. Medicine. 96(45). e8270–e8270. 2 indexed citations
13.
Ren, Fang, Jacson Shen, Huirong Shi, et al.. (2016). Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1866(2). 266–275. 88 indexed citations
14.
Liu, Ying, et al.. (2016). Radial free forearm flap versus pectoralis major pedicled flap for reconstruction in patients with tongue cancer: Assessment of quality of lif. Medicina oral, patología oral y cirugía bucal. 21(6). 0–0. 13 indexed citations
15.
Li, Zhisong, Dan Cheng, Yingying Du, et al.. (2015). Genetic Polymorphisms and Function of the Organic Anion-Transporting Polypeptide 1A2 and Its Clinical Relevance in Drug Disposition. Pharmacology. 95(3-4). 201–208. 37 indexed citations
16.
Zhou, Yubing, Chao Han, Duolu Li, et al.. (2015). Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth. Scientific Reports. 5(1). 10433–10433. 52 indexed citations
17.
Kan, Quancheng, Xiaojian Zhang, Yaojuan Chu, et al.. (2015). Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors. Experimental and Molecular Pathology. 99(2). 212–219. 15 indexed citations
18.
Gao, Guanmin, Zujiang Yu, Jingya Yan, et al.. (2015). Poly (ADP-ribose) polymerase- and cytochrome c-mediated apoptosis induces hepatocyte injury in a rat model of hyperammonia-induced hepatic failure. Molecular Medicine Reports. 11(6). 4211–4219. 5 indexed citations
19.
Gu, Chaohui, et al.. (2015). Introducing the Quill™ Device for Modified Sleeve Circumcision with Subcutaneous Suture: A Retrospective Study of 70 Cases. Urologia Internationalis. 94(3). 255–261. 5 indexed citations
20.
Jia, Bin, Edwin Choy, Gregory M. Coté, et al.. (2013). Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells. Cancer Letters. 342(1). 104–112. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihua Du Breakdown of academic impact, for papers by Meng Jia Breakdown of academic impact, for papers by Shanzhou Duan Breakdown of academic impact, for papers by Fengming You Breakdown of academic impact, for papers by Krishnendu Pal Breakdown of academic impact, for papers by Bin Kong Breakdown of academic impact, for papers by Renata Jaskula‐Sztul Breakdown of academic impact, for papers by Fangfang Chen Breakdown of academic impact, for papers by Xiao Xu
Rankless by CCL
2026